Discover 2,576 paid clinical trials in Illinois. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Illinois offers various clinical research options, including those for healthy volunteers interested in paid studies, as well as for individuals with specific health conditions. Leading research centers in Chicago, Plainfield, and Springfield are actively seeking participants, providing access to innovative treatments and personalized care.
Filter
1
Filter results
Results: 2,576
Study of MRM-3379 in Male Participants With Fragile X Syndrome (BLOOM)
for
Fragile X Syndrome
Location: Boston MA, Worcester MA, Media PA, Baltimore MD,
Sponsor: Mirum Pharmaceuticals, Inc.
Sex: Male
Age: 13 - 45
Code: NCT07209462
Phase2, Recruiting
Effects of Dihydroberberine (DHB) on GLP-1, Glycemic Control, Appetite, and Mood in Adults With Pre-Diabetes
for
Prediabetes
Location: Addison IL
Sponsor: Nanjing Nutrabuilding Bio-tech Co., Ltd.
Sex: All
Age: 35 - 65
Code: NCT07210684
Recruiting
Efficacy of Topical Mesenchymal Stromal Cell Secretome for Ocular Surface Disease
for
Persistent Corneal Epithelial Defect,
Location: Chicago IL
Sponsor: University of Illinois at Chicago
Sex: All
Age: 18+
Code: NCT06919081
Phase2, Recruiting
Tibial IMN Vs. Tibial Micromotion IMN
for
Tibial Fracture
Location: Chicago IL
Sponsor: University of Chicago
Sex: All
Age: 18+
Code: NCT06976801
Recruiting
A Study to Compare the Efficacy and Safety of TachoSil and Surgicel Original as an Adjunct to Control Mild to Moderate Soft Tissue Bleeding During Surgery
for
Hemorrhage
Location: Washington D.C. DC, Charlotte NC, Columbus OH,
Sponsor: Corza Medical GmbH
Sex: All
Age: 0+
Code: NCT06664775
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Dose-masked Study of Intravitreal EYE103 in Participants With NVAMD or Macular Edema Following BRVO
A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio
for
Geographic Atrophy Secondary to Age-related Macular Degeneration,
Location: Long Island City NY, Danbury CT, Great Neck NY,
Sponsor: Apellis Pharmaceuticals, Inc.
Sex: All
Age: 60+
Code: NCT07215390
Phase2, Recruiting
A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer
for
Prostate Cancer, Prostate Adenocarcinoma
Location: Chicago IL, Dallas TX, Portland OR
Sponsor: University of Chicago
Sex: Male
Age: 18+
Code: NCT05726292
Phase2, Recruiting
Chronic Low Back Pain and Osteopathic Manipulation Treatment